Summary
Reza Skandari joined Imperial College Business School in 2018. He is an Assistant Professor of Health Operations in the Operations Management group and affiliated with the Centre for Health Economics & Policy Innovation. Prior to that he worked as a Senior Research Analyst at the Center for Translational and Policy Research of Chronic Diseases at the University of Chicago School of Medicine. He obtained his PhD in Management Science from the Sauder School of Business, University of British Columbia.
Reza's main research interests are in: (1) Health-care Operations Management and Analytics (2) Health-care Policy Research and Economics (3) Clinical Decision Making (4) Dynamic Programming and Stochastic Optimization.
Publications
Journals
Alexander JT, Staab EM, Wan W, et al., 2021, The longer-term benefits and harms of glucagon-like peptide-1 receptor agonists: a systematic review and meta-analysis, Journal of General Internal Medicine, ISSN:0884-8734
Skandari MR, Shechter SM, 2021, Patient-Type Bayes-Adaptive Treatment Plans, Operations Research, Vol:69, ISSN:0030-364X, Pages:574-598
Dadwani RS, Skandari MR, GoodSmith MS, et al., 2020, Alternative type 2 diabetes screening tests may reduce the number of US adults with undiagnosed diabetes, Diabetic Medicine, Vol:37, ISSN:0742-3071, Pages:1935-1943
Miksanek TJ, Skandari M, Ham SA, et al., 2020, The productivity requirements of implementing a medical scribe program, Annals of Internal Medicine, ISSN:0003-4819
GoodSmith MS, Skandari M, Huang E, et al., 2019, The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing, Diabetes Care, Vol:42, ISSN:0149-5992, Pages:2247-2255